FIM
CLDX icon

Fernwood Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Fernwood Investment Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,903
Closed -$125K – 126
2016
Q2 		$125K Sell
1,903
-1,180
-38% -$74.9K 0.12% 110
2016
Q1 		$175K Sell
3,083
-627
-17% -$70.5K 0.18% 108
2015
Q4 		$873K Sell
3,710
-133
-3% -$29K 0.75% 38
2015
Q3 		$608K Hold
3,843
– – 0.53% 54
2015
Q2 		$1.45M Buy
3,843
+86
+2% +$34.2K 1.14% 32
2015
Q1 		$1.57M Buy
3,757
+1,667
+80% +$596K 1.29% 29
2014
Q4 		$572K Buy
2,090
+467
+29% +$116K 0.49% 63
2014
Q3 		$316K Buy
1,623
+373
+30% +$81.3K 0.27% 79
2014
Q2 		$306K Buy
1,250
+197
+19% +$44.5K 0.25% 80
2014
Q1 		$279K Hold
1,053
– – 0.26% 88
2013
Q4 		$383K Buy
+1,053
New +$406K 0.25% 95

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fernwood Investment Management's CLDX Position: Q3 2016 in Review

Fernwood Investment Management sold out of Celldex Therapeutics (CLDX) in Q3 2016, closing a stake of 1,903 shares — an estimated $125K sold.

Fernwood Investment Management first reported a position in CLDX in Q4 2013 and held it in 11 quarters. The position peaked at $1.57M in Q1 2015. 138 funds tracked by Wall St. Rank hold CLDX as of Q3 2016.

  • Fernwood Investment Management reported no remaining Celldex Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Fernwood Investment Management sold 1,903 Celldex Therapeutics shares in Q3 2016, an estimated $125K.
  • Fernwood Investment Management first reported a position in Celldex Therapeutics in Q4 2013 and held it in 11 quarters.
  • Fernwood Investment Management's Celldex Therapeutics position peaked at $1.57M in Q1 2015.
  • 138 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2016.

Based on Fernwood Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.